Financhill
Back

Day One Biopharmaceuticals Quote, Financials, Valuation and Earnings

Day One Biopharmaceuticals Price Quote

$15.11
+0.10 (+0.67%)
(Updated: October 17, 2024 at 6:55 PM ET)

Day One Biopharmaceuticals Key Stats

Buy
56
Day One Biopharmaceuticals (DAWN) is a Buy

Day range:
$14.82 - $15.53
52-week range:
$9.67 - $18.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.81%

Volume:
1.1M
Avg. volume:
980.2K
1-year change:
40.94%
Market cap:
$1.5B
Revenue:
$0
EPS:
$-1.95

How Much Does Day One Biopharmaceuticals Make?

Data Unavailable

Is Day One Biopharmaceuticals Growing As A Company?

Data Unavailable

Day One Biopharmaceuticals Stock Price Performance

What Is Day One Biopharmaceuticals 52-Week High & Low?

Day One Biopharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Day One Biopharmaceuticals?

Is Day One Biopharmaceuticals Cash Flow Positive?

  • What Is DAWN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$177.3M
  • What Is Day One Biopharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.1M
  • What Is Day One Biopharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $225.6M

Day One Biopharmaceuticals Return On Invested Capital

Data Unavailable

Day One Biopharmaceuticals Earnings Date & Stock Price

Day One Biopharmaceuticals Competitors

Day One Biopharmaceuticals Dividend Yield

Day One Biopharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 91.48%
Revenue: 0% 798.03%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 36.56
Upside from Last Price: 143.54%

Major Shareholders

  • How many DAWN shares are owned by institutional investors?
    129.1M DAWN shares are owned by institutional investors
  • How many DAWN shares are owned by insiders?
    1.6M DAWN shares are owned by insiders